We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Investigates reprogramming of cytotoxic CD8 T cells in vivo, suggesting new therapeutic avenues.
No takes yet. Share an insight, caveat, or question.
Corrigan et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: